NO20074515L - Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese - Google Patents
Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral pareseInfo
- Publication number
- NO20074515L NO20074515L NO20074515A NO20074515A NO20074515L NO 20074515 L NO20074515 L NO 20074515L NO 20074515 A NO20074515 A NO 20074515A NO 20074515 A NO20074515 A NO 20074515A NO 20074515 L NO20074515 L NO 20074515L
- Authority
- NO
- Norway
- Prior art keywords
- sample
- cerebral palsy
- autism
- behavioral analysis
- forecasting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for prognose for anvendt atferdsanalysebehandling for en mental sykdom, særlig autisme eller cerebral parese, i et menneske, hvor nevnte metode omfatter å analysere en prøve av kroppsvev eller fluid fra nevnte individ for nærvær eller fravær av en kjemisk markør som indikerer sannsynligheten for vellykkethet eller mislykkethet av anvendt atferdsanalysebehandling av nevnte mentalsykdom, og eventuelt, basert på nevnte analyse, å igangsette, fortsette eller avslutte anvendt atferdsanalysebehandling av nevnte individ. Prøven er fortrinnsvis en urinprøve og de foretrukne prognostiske markører er; glutenderivater, indolyl-3akryloylglysin (IAG), serotoninopptaksstimulator, p-kasomorfinamider, gliadinomorfin, P-kasomorfiner, deltorfiner, Demorfin, glutemorfin, gluten eksofiner, forbindelser med molekylvekt på 687 Dalton.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0504096.9A GB0504096D0 (en) | 2005-02-28 | 2005-02-28 | Method |
PCT/GB2006/000699 WO2006090185A1 (en) | 2005-02-28 | 2006-02-28 | Method of prognosis of mental diseases, e. g. autism and cerebral palsy |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074515L true NO20074515L (no) | 2007-09-06 |
Family
ID=34430346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074515A NO20074515L (no) | 2005-02-28 | 2007-09-06 | Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090011452A1 (no) |
EP (1) | EP1853922A1 (no) |
JP (1) | JP2008532033A (no) |
CN (1) | CN101189522A (no) |
AU (1) | AU2006217658A1 (no) |
CA (1) | CA2598945A1 (no) |
EA (1) | EA200701602A1 (no) |
GB (1) | GB0504096D0 (no) |
IL (1) | IL185554A0 (no) |
NO (1) | NO20074515L (no) |
WO (1) | WO2006090185A1 (no) |
ZA (1) | ZA200707230B (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2232263A4 (en) * | 2007-12-14 | 2013-11-27 | Univ Cornell | METHOD FOR DETERMINING THE EXCRETION OF SODIUM AND OTHER ANALYTES |
HUE039900T2 (hu) | 2010-03-22 | 2019-02-28 | Stemina Biomarker Discovery Inc | Gyógyszerek humán fejlõdésre gyakorolt toxicitásának elõrejelzése humán õssejtszerû sejtek és metabolomika alkalmazásával |
US9547013B2 (en) | 2010-04-29 | 2017-01-17 | Wisconsin Alumni Research Foundation | Molecule biomarkers of autism |
JP6679309B2 (ja) * | 2012-08-29 | 2020-04-15 | カリフォルニア インスティチュート オブ テクノロジー | 自閉症スペクトラム障害の診断および処置 |
US10060932B2 (en) | 2013-07-09 | 2018-08-28 | Stemina Biomarker Discovery, Inc. | Biomarkers of autism spectrum disorder |
US20150294081A1 (en) | 2014-04-11 | 2015-10-15 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
US9176113B1 (en) | 2014-04-11 | 2015-11-03 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
CA2966363A1 (en) | 2014-10-30 | 2016-05-06 | California Institute Of Technology | Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders |
EP3212207A4 (en) | 2014-10-30 | 2018-06-13 | California Institute of Technology | Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders |
US10525020B2 (en) | 2015-02-11 | 2020-01-07 | Laboratory Corporation Of America Holdings | Metabolic markers of attention deficit hyperactivity disorder |
CN105652016A (zh) * | 2016-01-28 | 2016-06-08 | 深圳大学 | 一种孤独症检测标志物及其检测方法 |
WO2017205302A1 (en) | 2016-05-23 | 2017-11-30 | California Institute Of Technology | Regulate gut microbiota to treat neurodegenerative disorders |
US10001103B1 (en) | 2016-12-15 | 2018-06-19 | Borgwarner, Inc. | System with multiple starters and smart relay |
WO2018213204A1 (en) | 2017-05-15 | 2018-11-22 | Axial Biotherapeutics, Inc. | Inhibitors of microbially induced amyloid |
RU2698634C1 (ru) * | 2019-03-18 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития детского церебрального паралича у детей, родившихся в сроке сверхранних преждевременных родов, на первом году жизни |
CN115616227B (zh) * | 2022-11-18 | 2023-05-16 | 四川大学华西医院 | 吲哚-3-丙烯酰甘氨酸检测试剂的用途、诊断或辅助诊断慢性阻塞性肺病的试剂盒及系统 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197746B1 (en) * | 1998-05-19 | 2001-03-06 | Repligen Corporation | Method of using secretin for treating autism |
CA2273683A1 (en) * | 1998-06-15 | 1999-12-15 | Ortho-Clinical Diagnostics, Inc. | Diagnostic markers for human disorders |
US6534063B1 (en) * | 1999-12-17 | 2003-03-18 | Joan M. Fallon | Methods for treating pervasive development disorders |
JP4299243B2 (ja) * | 2002-07-04 | 2009-07-22 | 田辺三菱製薬株式会社 | 統合失調症の検査、診断方法 |
FR2857452B1 (fr) * | 2003-07-11 | 2005-09-30 | Univ Rabelais Francois | Test de depistage de l'autisme, methode de selection de patients repondant audit test et utilisation des medicaments activateurs de canaux bkca pour le traitement de ladite maladie |
DE602004021186D1 (de) * | 2003-08-22 | 2009-07-02 | Integragen Sa | Menschliches autismus-suszeptibilitätsgen und verwendungen davon |
-
2005
- 2005-02-28 GB GBGB0504096.9A patent/GB0504096D0/en not_active Ceased
-
2006
- 2006-02-28 CN CNA2006800145644A patent/CN101189522A/zh active Pending
- 2006-02-28 WO PCT/GB2006/000699 patent/WO2006090185A1/en active Application Filing
- 2006-02-28 AU AU2006217658A patent/AU2006217658A1/en not_active Abandoned
- 2006-02-28 EA EA200701602A patent/EA200701602A1/ru unknown
- 2006-02-28 JP JP2007557576A patent/JP2008532033A/ja active Pending
- 2006-02-28 CA CA002598945A patent/CA2598945A1/en not_active Abandoned
- 2006-02-28 EP EP06709924A patent/EP1853922A1/en not_active Withdrawn
- 2006-02-28 ZA ZA200707230A patent/ZA200707230B/xx unknown
- 2006-02-28 US US11/817,184 patent/US20090011452A1/en not_active Abandoned
-
2007
- 2007-08-28 IL IL185554A patent/IL185554A0/en unknown
- 2007-09-06 NO NO20074515A patent/NO20074515L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1853922A1 (en) | 2007-11-14 |
CA2598945A1 (en) | 2006-08-31 |
IL185554A0 (en) | 2008-01-06 |
US20090011452A1 (en) | 2009-01-08 |
GB0504096D0 (en) | 2005-04-06 |
EA200701602A1 (ru) | 2008-02-28 |
ZA200707230B (en) | 2008-11-26 |
AU2006217658A1 (en) | 2006-08-31 |
JP2008532033A (ja) | 2008-08-14 |
WO2006090185A1 (en) | 2006-08-31 |
CN101189522A (zh) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074515L (no) | Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese | |
DE60326214D1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
WO2005033652A3 (en) | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol | |
BRPI0720035A2 (pt) | métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit | |
WO2006073682A3 (en) | Diagnostic test | |
WO2007072225A3 (en) | Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy | |
WO2008138578A3 (en) | Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy | |
ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
WO2005098041A3 (en) | Detection and treatment of fibrotic disorders | |
NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
WO2006081521A3 (en) | Methods for diagnosis and intervention of hepatic disorders | |
WO2005098429A3 (en) | System and method for real-time diagnosis, treatment, and therapeutic drug monitoring | |
WO2008055491A3 (de) | Diagnose und risikostratifizierung von diabetes mellitus mittels mr-proadm | |
BRPI0602485A (pt) | aparelho e método para a condução de testes clìnicos em grande escala | |
SG150497A1 (en) | Methods and devices for diagnosis of appendicitis | |
WO2008070663A3 (en) | Companion diagnostic assays for cancer therapy | |
DK2185939T3 (da) | Engangsanalyseudstyr med mikroprocessor | |
MX2017013390A (es) | Método para el tratamiento de cáncer pulmonar. | |
DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
Wang et al. | Emerging intraoral biosensors | |
WO2002090925A3 (en) | Polypeptides and nucleic acids associated with cancer | |
WO2005015155A3 (en) | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol | |
WO2008145701A9 (en) | Method for predicting the outcome of a critically ill patient | |
WO2005056839A3 (de) | Primer und sonden zum nachweis genitaler hpv-genotypen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |